文献速递冠心病外科

冠状动脉旁路移植术后心包切除术:风险与疗效分析

Pericardiectomy After Previous Bypass Grafting: Analyzing Risk and Effectiveness in this Rare Clinical Entity.
PubMed 文献 · Ann Thorac Surg · 2016-11-05

该研究回顾了1993年至2013年间98例既往行冠状动脉旁路移植术(CABG)后因心包缩窄接受心包切除术的患者。早期死亡率为3%,5年和10年生存率分别为62%和41%。体外循环使用是总生存率较低的唯一致险因素(HR 1.96,95%CI 1.03-3.7,P=0.04)。随访中84%的患者NYHA心功能分级改善至I/II级。

要点

  • CABG后心包缩窄行心包切除术的早期死亡率低(3%)。
  • 体外循环使用与较差的远期生存相关,可能反映疾病严重程度更高。
  • 绝大多数患者远期NYHA心功能分级显著改善。

核心结论

  • 对于既往CABG后发生心包缩窄的患者,心包切除术早期死亡率低,且大多数患者远期心功能显著改善。
  • 体外循环的使用是总生存率较低的唯一致险因素,可能反映疾病严重程度和技术复杂性增加。

研究设计与样本

  • 中位年龄68岁(范围38-81岁),男性91例(93%),术前中位左室射血分数60%(范围30%-71%),中位NYHA分级III级(91%为III/IV级)。

主要发现

  • 早期死亡3例(3%),中位远期随访3.2年(最长17.5年),5年和10年总生存率分别为62%和41%。
  • 单因素分析显示体外循环使用是总生存率较低的唯一致险因素(HR 1.96,95%CI 1.03-3.7,P=0.04),无多因素预测因子。
  • 中位随访3.2年时,84%的患者NYHA心功能分级为I/II级。

关键数值与推荐

  • 手术入路:正中胸骨切开81例(83%),左胸切开16例(16%),蛤壳切口1例(1%)。
  • 心包切除范围:根治性61例(62%),次全切除27例(28%),完成性切除10例(10%)。
  • 体外循环使用63例(64%),主动脉阻断5例(5%),同期CABG 10例(10%)。

临床怎么用

  • 对于CABG后出现心包缩窄的患者,心包切除术可考虑作为有效治疗选择,早期风险可接受。
  • 术前应评估体外循环使用的必要性,因其与较差的远期生存相关,可能需个体化权衡手术策略。

局限性

  • 回顾性单中心研究,样本量有限(98例),可能存在选择偏倚。
  • 无多因素预测因子,单因素分析结果需谨慎解读。
  • 缺乏非手术对照组,无法直接比较手术与保守治疗的疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Historically the most common causes of pericarditis necessitating pericardiectomy are infection, radiation, idiopathic causes, and inflammation. More recently, there has been a rise in iatrogenic pericardial constriction, with most cases occurring after coronary artery bypass grafting (CABG). To date, there has been no large series evaluating the incidence, presentation, and effectiveness of surgical intervention. We review our 20-year experience managing this special subset of patients. METHODS: From January 1993 to December 2013, 938 patients underwent pericardiectomy at our institution. We identified 98 patients who underwent pericardiectomy after previous coronary bypass grafting. Demographic information was collected along with the indication for the procedure, technical aspects of the operation, early and late morbidity and mortality, and long-term New York Heart Association (NYHA) functional class. Median age at operation was 68 years (range, 38-81 years), and 91 of the patients (93%) were men. The indication for pericardiectomy was pericardial constriction in all patients. Median preoperative left ventricular ejection fraction was 60% (range, 30%-71%) and median NYHA functional class was III (91% were class III/IV). RESULTS: The surgical approach was median sternotomy in 81 patients (83%), left thoracotomy in 16 patients (16%), and a clamshell approach in 1 patient (1%). The extent of pericardial resection was radical in 61 patients (62%), subtotal in 27 patients (28%), and completion in 10 patients (10%). Cardiopulmonary bypass was used in 63 patients (64%) and aortic cross-clamping was used in 5 patients (5%). Concomitant coronary bypass grafting was performed in 10 patients (10%). Early mortality was seen in 3 of 98 patients (3%). The median duration of late follow-up was 3.2 years (maximum, 17.5 years), and overall 5- and 10-year survival was 62% and 41%, respectively. There were no multivariate predictors of worse outcome. The sole univariate predictor of lower overall survival was the use of cardiopulmonary bypass (hazard ratio, 1.96; 95% confidence interval, 1.03-3.7]; p = 0.04). NYHA functional class was I/II in 84% of patients at a median follow-up of 3.2 years. CONCLUSIONS: The rate of early mortality for pericardiectomy after previous coronary bypass grafting is low, and the late adverse impact of cardiopulmonary bypass likely reflects increased severity of disease and technical complexity. Importantly, during late follow-up extending more than 17 years, the vast majority of patients demonstrated significant improvement in NYHA functional class.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Gillaspie EA, Dearani JA, Daly RC, et al. Pericardiectomy After Previous Bypass Grafting: Analyzing Risk and Effectiveness in this Rare Clinical Entity. Ann Thorac Surg. 2016. PMID: 27825685. doi:10.1016/j.athoracsur.2016.08.087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。